Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma

Author： van Klaveren R.J.   Aerts J.G.J.V.   de Bruin H.   Giaccone G.   Manegold C.   van Meerbeeck J.P.  

Publisher： Elsevier

ISSN： 0169-5002

Source： Lung Cancer, Vol.43, Iss.1, 2004-01, pp. : 63-69

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Inadequacy of the new Response Evaluation Criteria in Solid Tumors (RECIST) in patients with malignant pleural mesothelioma: report of four cases

By Monetti F.   Casanova S.   Grasso A.   Cafferata M.A.   Ardizzoni A.   Neumaier C.E.  

Lung Cancer, Vol. 43, Iss. 1, 2004-01 ,pp. : 71-74

Elsevier

Access to resources Recommend Favorite

Chemotherapy for Malignant Pleural Mesothelioma

By Garland Linda  

Current Treatment Options in Oncology, Vol. 12, Iss. 2, 2011-06 ,pp. : 181-188

Springer Publishing Company

Access to resources Recommend Favorite

Malignant pleural mesothelioma

By Stahel Rolf A   Felley-Bosco Emanuela   Opitz Isabelle   Weder Walter  

Future Oncology, Vol. 5, Iss. 3, 2009-04 ,pp. : 391-402

Future Medicine

Access to resources Recommend Favorite

Disease volumes as a marker for patient response in malignant pleural mesothelioma

By Labby Z. E.   Nowak A. K.   Dignam J. J.   Straus C.   Kindler H. L.   Armato S. G.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 999-1005

Oxford University Press

Access to resources Recommend Favorite

A phase II EORTC study of temozolomide in patients with malignant pleural mesothelioma

By van Meerbeeck J.P.   Baas P.   Debruyne C.   Smit E.F.   van Klaveren R.J.   Galdermans D.   Lentz M.A.   Manegold C.   Giaccone G.   for the EORTC Lung Cancer Group  

European Journal of Cancer, Vol. 38, Iss. 6, 2002-01 ,pp. : 779-783

Elsevier

Access to resources Recommend Favorite